New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
16:24 EDTNLSN, SWHC, GTAT, ARB, ORCL, HEB, RGROn The Fly: Closing Wrap
Stocks on Wall Street were higher, with the buying spurred on by optimism surrounding the fiscal cliff negotiations. After surging higher during the first half of the trading session, the averages moved in a narrow range through the afternoon, though held onto gains and closed right near their highs... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: After the bell, Oracle (ORCL) reported earnings and revenues that beat Street expectations. Shares, which had been up 1.67% during the trading session, moved up another 1.5% in after hours trading following the report... Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as private equity firm Cerberus Capital Management's decision to put gunmaker Freedom Group up for sale added new pressure on those stocks. Shares of Smith & Wesson lost 86c, or 9.99%, to close at $7.79, while shares of Sturm, Ruger fell $3.40, or 7.73%, to close at $40.60... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up $8.99, or 23.63%, to $47.03 after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also gained $1.30, or 4.39%, to $30.92. Among the noteworthy losers was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw shares fall 39c, or 11.27%, to $3.07 after issuing guidance well below consensus. Also lower was Hemispherex Biopharma (HEB), down 27.6c, or 42.86%, to 36.8c, after the FDA posted documents in advance of a review of the company's Ampligen drug, noting that the agency had concerns with the drug's efficacy and safety data... INDICES: The Dow was up 115.57, or 0.87%, to 13,350.96; the Nasdaq was up 43.93, or 1.46%, to 3,054.53; and the S&P 500 was up 16.43, or 1.15%, to 1,446.79.
News For ORCL;SWHC;RGR;ARB;NLSN;HEB;GTAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
06:00 EDTORCLOracle implied volatility of 16 at lower end of index mean range
Subscribe for More Information
July 30, 2015
10:00 EDTORCLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:29 EDTORCLOracle upgraded to Buy from Hold at Jefferies
Jefferies analysts John DiFucci and Brad Zelnick upgraded Oracle to Buy and raised their price target for shares to $50 from $41. The software giant closed yesterday up 52c to $39.80. The 12c/Exadata product cycle will keep Oracle relevant in the Cloud, the analysts tell investors in a research note. Further, alternative database technologies like Hadoop and NoSQL "are not a death knell," they write. The analysts believe that some enterprises will continue to require on-premise solutions.
July 29, 2015
06:59 EDTNLSNNielsen price target raised to $53 following Q2 results at Barclays
Subscribe for More Information
July 28, 2015
19:10 EDTRGROn The Fly: After Hours Movers
Subscribe for More Information
17:08 EDTRGRSturm, Ruger declares Q2 dividend of 36c per share
The company announced that its Board of Directors declared a dividend of 36c per share for the second quarter for stockholders of record as of August 14, payable on August 28. This dividend varies every quarter because the company pays a percent of earnings rather than a fixed amount per share. This dividend is approximately 40% of net income.
17:06 EDTRGRSturm, Ruger reports Q2 EPS 91c, consensus 78c
Subscribe for More Information
10:07 EDTNLSNHigh option volume stocks
Subscribe for More Information
08:19 EDTNLSNNielsen sees FY15 adjusted EPS $2.60-$2.66, consensus $2.62
Sees FY15 revenue up 4%-6%. Guidance provided in Q2 earnings presentation slides.
06:35 EDTNLSNNielsen reports Q2 Buy segment revenue down 5.3% to $852M
Subscribe for More Information
06:34 EDTNLSNNielsen reports Q2 adjusted EPS 66c, consensus 64c
Reports Q2 revenue $1.56B, consensus $1.55B.
05:41 EDTORCLOracle FLEXCUBE selected by Maitland Group to deliver transfer agency services
Subscribe for More Information
July 27, 2015
15:03 EDTNLSNNotable companies reporting before tomorrow's open
Subscribe for More Information
11:01 EDTORCLFederal Court increase damages amount Oracle can seek against Rimini Street
Subscribe for More Information
06:58 EDTORCLOracle using 'nuclear option' to sell its cloud products, Business Insider says
Subscribe for More Information
July 24, 2015
09:41 EDTRGRSturm, Ruger initiated with a Buy at BB&T
Subscribe for More Information
09:41 EDTSWHCSmith & Wesson initiated with a Hold at BB&T
Subscribe for More Information
July 23, 2015
08:36 EDTHEBHemispherx announces final approval of securities class action settlement
Subscribe for More Information
06:32 EDTORCLOracle requests permission to update suit against Google, Reuters reports
Oracle (ORCL) has requested permission from a U.S. judge to update its copyright lawsuit against Google (GOOG) to include the Android operating system's current market dominance, Reuters reports. Oracle has said it wants the suit to add that Google continues its copyright infringement through updated versions of Android, the report says. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use